Systemic IFN-α drives kidney nephritis in B6.Sle123 mice

被引:77
作者
Fairhurst, Anna-Marie [1 ]
Mathian, Alexis [3 ]
Connolly, John E. [4 ]
Wang, Andrew [1 ]
Gray, Hillery F. [1 ]
George, Tiffany A. [1 ]
Boudreaux, Christopher D. [1 ]
Zhou, Xin J. [2 ]
Li, Quan-Zhen [5 ]
Koutouzov, Sophie [5 ]
Banchereau, Jacques [4 ]
Wakeland, Edward K. [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
[3] Hop La Pitie Salpetriere, Med Interna Serv 2, Paris, France
[4] Baylor Inst Immunol Res, Dallas, TX USA
[5] Inst Natl Sante & Rech Med, U764, Clamart, France
关键词
Congenic; IFN; systemic lupus erythematosus;
D O I
10.1002/eji.200837925
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The impact of IFN-alpha secretion on disease progression was assessed by comparing phenotypic changes in the lupus-prone B6.Sle1Sle2Sle3 (B6.Sle123) strain and the parental C57BL/6 (B6) congenic partner using an adenovirus (ADV) expression vector containing a recombinant IFN-a gene cassette (IFN-ADV). A comprehensive comparison of cell lineage composition and activation in young B6 and B6.Sle123 mice revealed a variety of cellular alterations in the presence and absence of systemic IFN-alpha. Most IFN-alpha-induced phenotypes were similar in B6 and B6.Sle123 mice; however, B6.Sle123 mice uniquely exhibited increased B1 and plasma cells after IFN-a exposure, although both strains had an overall loss of mature B cells in the bone marrow, spleen and periphery. Although most of the cellular effects of IFN-a were identical in both strains, severe glomerulonephritis occurred only in B6.Sle123 mice. Mice injected with IFN-ADV showed an increase in immune complex deposition in the kidney, together with an unexpected decrease in serum anti-nuclear antibody levels. In summary, the predominant impact of systemic IFN-a in this murine model is an exacerbation of mechanisms mediating end organ damage.
引用
收藏
页码:1948 / 1960
页数:13
相关论文
共 58 条
[1]   A Toll for lupus [J].
Anders, HJ .
LUPUS, 2005, 14 (06) :417-422
[2]   Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice [J].
Anders, HJ ;
Vielhauer, V ;
Eis, V ;
Linde, Y ;
Kretzler, M ;
de Lema, GP ;
Strutz, F ;
Bauer, S ;
Rutz, M ;
Wagner, H ;
Gröne, HJ ;
Schlbndorff, D .
FASEB JOURNAL, 2004, 18 (01) :534-+
[3]   Bacterial CpG-DNA aggravates immune complex glomerulonephritis:: Role of TLR9-mediated expression of chemokines and chemokine receptors [J].
Anders, HJ ;
Banas, B ;
Linde, Y ;
Weller, L ;
Cohen, CD ;
Kretzler, M ;
Martin, S ;
Vielhauer, V ;
Schlöndorff, D ;
Gröne, HJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (02) :317-326
[4]   Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus [J].
Baechler, EC ;
Batliwalla, FM ;
Karypis, G ;
Gaffney, PM ;
Ortmann, WA ;
Espe, KJ ;
Shark, KB ;
Grande, WJ ;
Hughes, KM ;
Kapur, V ;
Gregersen, PK ;
Behrens, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2610-2615
[5]   Interferon and granulopoiesis signatures in systemic lupus erythematosus blood [J].
Bennett, L ;
Palucka, AK ;
Arce, E ;
Cantrell, V ;
Borvak, J ;
Banchereau, J ;
Pascual, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (06) :711-723
[6]   Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus [J].
Blanco, P ;
Palucka, AK ;
Gill, M ;
Pascual, V ;
Banchereau, J .
SCIENCE, 2001, 294 (5546) :1540-1543
[7]   Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice [J].
Braun, D ;
Geraldes, P ;
Demengeot, J .
JOURNAL OF AUTOIMMUNITY, 2003, 20 (01) :15-25
[8]   Fas death receptor signaling represses monocyte numbers and macrophage activation in vivo [J].
Brown, NJ ;
Hutcheson, J ;
Bickel, E ;
Scatizzi, JC ;
Albee, LD ;
Haines, GK ;
Eslick, J ;
Bradley, K ;
Taricone, E ;
Perlman, H .
JOURNAL OF IMMUNOLOGY, 2004, 173 (12) :7584-7593
[9]   Microarray analysis of gene expression in lupus [J].
Crow, MK ;
Wohlgemuth, J .
ARTHRITIS RESEARCH & THERAPY, 2003, 5 (06) :279-287
[10]   Type I interferon correlates with serological and clinical manifestations of SLE [J].
Dall'Era, MC ;
Cardarelli, PM ;
Preston, BT ;
Witte, A ;
Davis, JC .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (12) :1692-1697